resources

Orchid Pharma Ltd.

NSE: ORCHPHARMA

BSE: 524372

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

823.30-53.7 (-6.12%)

23 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Orchid Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Jun Sept Dec	—	Jun Sept Dec	Jun Dec	Mar Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	24Feb 17Aug 23Nov	22Feb 18May 10Nov	13Feb 29May 17Aug 15Nov	15Feb 2Jun 14Aug 17Nov	16Feb 1Jun 24Aug
Presentations	—	—	—	—	—	—	—	9Jun 16Jun 23Nov 23Dec	20Jun 10Aug 15Dec	14Aug 21Aug 6Nov 20Nov	8Feb 23May 13Aug 11Nov	12Feb 26May 12Aug 11Nov	26May 20Aug

Corporate Announcements and Regulatory Filings

Orchid Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Raising of Funds20 Oct 2026
Announcement under Regulation 30 (LODR)-Raising of Funds
Outcome of Board Meeting for Raising Funds ("Enabling Resolution")
Outcome of Board Meeting20 Oct 2026
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting
Board Meeting15 Oct 2026
Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On October 20, 2026.
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2026 ,inter alia, to consider and approve Prior intimation of Board Meeting ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018
AGM3 Oct 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s Report and Voting Result-33rd Annual General Meeting of Orchid Pharma Limited
AGM29 Sept 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 33rd Annual General Meeting of Orchid Pharma Limited Held on 29th September 2026
Closure of Trading Window28 Sept 2026
Closure of Trading Window
Intimation of Trading Window closure for Quarter-II of Financial Year 2026-27, ending on September 30, 2026.
General23 Sept 2026
Intimation Under Regulation 30- Trading Approval Of Equity Shares Issued And Allotted Under Scheme Of Amalgamation
Intimation under regulation 30- Trading Approval of Equity Shares issued and allotted under Scheme of Amalgamation
General22 Sept 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement Regulations), 2015
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015
General21 Sept 2026
Investor Roadshow Scheduled To Be Held In Mumbai
Investor roadshow scheduled to be held in Mumbai
Reg. 34 (1) Annual Report8 Sept 2026
Reg. 34 (1) Annual Report.
Annual Report of the Company for FY 2025-26.
Business Responsibility and Sustainability Reporting (BRSR)8 Sept 2026
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for FY 2025-26
Change in Management3 Sept 2026
Announcement under Regulation 30 (LODR)-Change in Management
Appointment of cost auditor for FY 2026-27 and change in designation of director.
Outcome without intimation3 Sept 2026
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board meeting.
Analyst / Investor Meet21 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of the Analyst/Investor Earning Call for Q-1 ended on June 30, 2026
Analyst / Investor Meet17 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of Analysts/Investors Earning call for the Quarter-1 ended on June 30, 2026.
Reg. 32 (1), (3) - Statement of Deviation & Variation14 Aug 2026
Statement Of Deviation Or Variation For The Quarter Ended June 30, 2026 On The Use Of Proceeds Of Funds Raised Through Qualified Institutional Placement
Statement of Deviation or variation for the quarter ended June 30, 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.
Monitoring Agency Report14 Aug 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report for Quarter-1 of F.Y. 2026-27 ended June 30, 2026.
General14 Aug 2026
Outcome Of Board Meeting Held For Considering And Approving Revised Audited Financial Results For The Year Ended March 31, 2026 Pursuant To Scheme Of Merger.
Revised Audited financial results for the Financial year ended March 31, 2026 pursuant to Scheme of Merger
Outcome of Board Meeting14 Aug 2026
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board meeting inter alia for considering and approving Unaudited Financial Results for Quarter-1 of F.Y. 2026-27, ended on June 30, 2026.

Frequently Asked Questions

Where can I download the annual report of Orchid Pharma Ltd.?

Annual reports of Orchid Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Orchid Pharma Ltd.?

Quarterly earnings results and presentations of Orchid Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Orchid Pharma Ltd. publish earnings call transcripts?

Earnings call transcripts of Orchid Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Orchid Pharma Ltd.?

Investor presentations and annual day presentations of Orchid Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Orchid Pharma Ltd.?

Corporate announcements and regulatory filings of Orchid Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Orchid Pharma Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Orchid Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Orchid Pharma Ltd.?

The ISIN (International Securities Identification Number) of Orchid Pharma Ltd. is INE191A01027. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Orchid Pharma Ltd. listed?

Orchid Pharma Ltd. is listed on NSE and BSE. The NSE symbol is ORCHPHARMA and the BSE code is -.

Where can I find the shareholding pattern of Orchid Pharma Ltd.?

The quarterly shareholding pattern of Orchid Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Orchid Pharma Ltd. on Sharpely?

Share price data for Orchid Pharma Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.